| Literature DB >> 29125590 |
Shaokui Yi1, Yanhe Li2, Linlin Shi3, Long Zhang4.
Abstract
White spot syndrome virus (WSSV), one of the major pathogens of Procambarus clarkii, has caused severe disruption to the aquaculture industry of P. clarkii in China. To reveal the gene regulatory mechanisms underlying WSSV infection, a comparative transcriptome analysis was performed among WSSV-infected susceptible individuals (GS), viral resistant individuals (GR), and a non-infected control group (GC). A total of 61,349 unigenes were assembled from nine libraries. Subsequently, 515 and 1033 unigenes exhibited significant differential expression in sensitive and resistant crayfish individuals compared to the control group (GC). Many differentially expressed genes (e.g., C-type lectin 4, Peroxinectin, Prophenoloxidase, and Serine/threonine-protein kinase) observed in GR and GS play critical roles in pathogen recognition and viral defense reactions after WSSV infection. Importantly, the glycosaminoglycan biosynthesis-chondroitin sulfate/dermatan sulfate pathway was identified to play critical roles in defense to WSSV infection for resistant crayfish individuals by upregulating the chondroitin sulfate related genes for the synthesis of WSSV-sensitive, functional chondroitin sulfate chains containing E units. Numerous genes and the key pathways identified between resistant and susceptible P. clarkii individuals provide valuable insights regarding antiviral response mechanisms of decapoda species and may help to improve the selective breeding of P. clarkii WSSV-resistance.Entities:
Keywords: Procambarus clarkii; RNA-Seq; immune response; white spot syndrome virus
Year: 2017 PMID: 29125590 PMCID: PMC5704233 DOI: 10.3390/genes8110320
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
The sequencing information from nine RNA-seq libraries.
| Group | Sample | Raw Reads | Clean Reads | Clean Bases (Gb) | Valid Ratio (base) | GC Content (%) |
|---|---|---|---|---|---|---|
| GC | G1_E22 | 85,792,014 | 84,216,344 | 9.80 | 98.11% | 46.00 |
| G1_E23 | 83,021,208 | 81,364,944 | 9.47 | 97.95% | 46.00 | |
| G1_E25 | 95,650,310 | 93,818,350 | 10.92 | 98.03% | 46.00 | |
| GR | G2_E31 | 76,276,920 | 74,917,080 | 8.72 | 98.16% | 44.00 |
| G2_E39 | 80,384,048 | 78,772,012 | 9.17 | 97.94% | 45.00 | |
| G2_E40 | 67,638,948 | 66,384,842 | 7.72 | 98.09% | 44.50 | |
| GS | G3_E6 | 81,888,888 | 80,253,434 | 9.34 | 97.95% | 44.00 |
| G3_E8 | 67,330,090 | 65,977,146 | 7.68 | 97.93% | 43.50 | |
| G3_E11 | 72,882,090 | 71,117,604 | 8.27 | 97.52% | 45.00 |
GC, non-infected control group; GR, viral resistant individuals; GS, white spot syndrome virus (WSSV)-infected susceptible individuals.
Figure 1Scatter plots of the differentially expressed genes in GS vs. GC (A), GR vs. GC (B) and GR vs. GS (C). The blue scatters indicate the downregulated genes, and the red scatters indicate the upregulated genes.
Figure 2The number of differentially expressed genes (DEGs) from pairwise comparison in three Procambarus clarkii groups. The histogram graph showed the number of DEGs in each pairwise comparisons (A); Three-way Venn diagram of all evidencing numbers of the DEGs identified in the three comparisons (B).
The candidate genes involved in the antiviral response for P. clarkii.
| Unigene | Fold Change (GS/GR) | Log2FC | Annotation | FDR |
|---|---|---|---|---|
| CL41502Contig1 | 9.4600 | 3.2426 | C-type lectin-2 ( | 0.0298 |
| CL19887Contig1 | 4.9525 | 2.3081 | C-type lectin 4 ( | 0.0071 |
| CL8034Contig1 | 3.7954 | 1.9243 | innexin inx2 ( | 0.0015 |
| CL46545Contig1 | 0.2819 | −1.8267 | serine proteinase inhibitor ( | 0.0028 |
| CL29567Contig1 | 0.2568 | −1.9611 | serine protease ( | 0.0024 |
| CL26397Contig1 | 0.2136 | −2.2273 | serine proteinase-like protein 1 ( | 0.0006 |
| comp98966_c2_seq4_1 | 0.1704 | −2.5531 | Serine/threonine protein kinase | 0.0416 |
| CL3961Contig1 | 0.3847 | −1.3783 | MAP kinase-interacting serine/threonine-protein kinase 1 ( | 0.0191 |
| comp120608_c2_seq2_2 | 0.3304 | −1.5976 | mitogen-activated protein kinase p38 ( | 0.0080 |
| CL31899Contig1 | 0.2222 | −2.1703 | peroxinectin ( | 0.0042 |
| CL15404Contig1 | 0.3836 | −1.3821 | integrin ( | 0.0319 |
| CL31391Contig1 | 0.2081 | −2.2647 | prophenoloxidase ( | 0.0115 |
| CL29721Contig1 | 0.0551 | −4.1813 | DnaJ domain protein ( | 0.0081 |
| CL42408Contig1 | 0.1135 | −3.1388 | heat shock protein ( | 0.0473 |
| CL47461Contig1 | 0.0701 | −3.8347 | heat shock protein 21 ( | 8.53 × 10−6 |
| CL44350Contig1 | 0.1803 | −2.4717 | insulin-like growth factor binding protein 7-like protein ( | 0.0002 |
| CL45485Contig1 | 0.1612 | −2.6327 | serpin8 ( | 0.0044 |
| comp104708_c1_seq2_1 | 0.4205 | −1.2497 | ubiquitin ( | 0.0284 |
| comp125239_c0_seq4_2 | 0.1409 | −2.8269 | aserpin | 0.0012 |
| comp94348_c1_seq1_3 | 0.2895 | −1.7884 | ferritin 3 ( | 0.0267 |
| CL3118Contig1 | 2.5278 | 1.3379 | chitinase ( | 0.0238 |
GR, viral resistant individuals; GS, white spot syndrome virus (WSSV)-infected susceptible individuals; FDR, false discovery rate.
The differentially expressed genes involved in glycosaminoglycan biosynthesis.
| Unigene ID | Gene Name | Gene Description | log2FC (GS vs.GC) | log2FC (GR vs.GC) | KO Entry |
|---|---|---|---|---|---|
| CL11558Contig1 | Chondroitin sulfate N-acetylgalactosaminyltransferase 1 | −3.06 | 3.15 | K00746 | |
| CL41630Contig1 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | −4.33 | 4.12 | K00746 | |
| CL47518Contig1 | Carbohydrate sulfotransferase 11 | −4.41 | 5.05 | K01017 | |
| CL6249Contig1 | Carbohydrate sulfotransferase 13 | NA | 3.80 | K01017 | |
| CL8068Contig1 | carbohydrate sulfotransferase 14 | −2.84 | 2.81 | K01017 | |
| CL45134Contig1 | Carbohydrate sulfotransferase 15 | −2.45 | NA | K08106 |
KO, KEGG Orthology; NA, not available.
Figure 3The pathway of glycosaminoglycan biosynthesis in P. clarkii and the related genes up- or downregulated in GS and GR. The unigene identity was colored in red; the green boxes represent the upregulated or downregulated gene(s); the numbers in the brackets indicate log2 (fold change).
Figure 4Quantitative real-time PCR (qRT-PCR) validation (A) and linear regression analysis (B) of RNA sequencing of selected DEGs.